GSK Investigational Site

Vsevolozhsk 188663

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling — Completed